J.P. Morgan raises Novo Nordisk target on stronger Ozempic, Wegovy sales

J.P. Morgan raises Novo Nordisk target on stronger Ozempic, Wegovy sales
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.